Navigation Links
Croff Enterprises, Inc. Closes Merger and Will Change Name to America's Minority Health Network, Inc.
Date:7/27/2009

LOS ANGELES, July 27 /PRNewswire-FirstCall/ -- Croff Enterprises, Inc. (OTC Bulletin Board: COFF) announced today that it has closed on its previously announced merger with America's Minority Health Network, Inc., a development stage corporation that is engaged in providing direct to consumer television programming in medical offices that are focused on delivering health care to members of African-American communities and other minorities located across the United States. AMHN's innovative programming combines increased health education awareness to patients and families visiting their physicians and medical care givers while also delivering targeted advertising that may effectively address community concerns and interests. In connection with the merger, Croff issued 13,693,689 shares of common stock to acquire AMHN, which will continue to operate as a wholly owned subsidiary. After giving effect to a 3 for 1 share split and the return by a shareholder of certain shares of common stock for cancellation by the company, there are a total of 15,215,210 shares of common stock issued and outstanding. Croff announced on July 10, 2009 that the parties signed a definitive merger agreement and that they expected to complete the transaction before July 31, 2009.

The board of directors of Croff also announced following the merger that they intend to notice and call for a special meeting of shareholders to change the name of the corporation to "America's Minority Health Network, Inc."

About Croff:

Croff was incorporated in Utah in 1907 under the name "Croff Mining Company." Croff changed its name to "Croff Oil Company" in 1952, and in 1996 changed its name to the current "Croff Enterprises, Inc." Croff does not currently maintain a website. Croff currently has no business operations or revenue source and has reduced its operations to a minimal level (although it continues to file reports required under the Securities Exchange Act of 1934). As a result, Croff was a "shell company" under the rules of the Securities and Exchange Commission until completion of the merger on July 27, 2009. Following the merger, the business of AMHN has become the sole business of the Company. Consistent with the rules of the SEC, the Company intends to file with the SEC a current report on Form 8-K providing a detailed description of the business, operations, risk and other factors affecting AMHN, management, and financial statements and other information relating to AMHN.

Forward Looking Statements:

This release contains forward-looking statements. Actual results may differ from those projected due to a number of risks and uncertainties, including, but not limited to the possibility that some or all of the pending matters and transactions considered by Croff may not proceed as contemplated, particularly if any conditions to closing are not satisfied, and by all other matters specified in Croff's filings with the Securities and Exchange Commission. These statements are made based upon current expectations that are subject to risk and uncertainty. Croff does not undertake to update forward-looking statements in this news release to reflect actual results, changes in assumptions or changes in other factors affecting such forward-looking information. Assumptions and other information that could cause results to differ from those set forth in the forward-looking information can be found in the Croff's filings with the Securities and Exchange Commission, including its most recent periodic report.


'/>"/>
SOURCE Croff Enterprises, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Croff Enterprises, Inc. Agrees to Merge With Americas Minority Health Network, Inc.
2. Dr. Andrew K. Palmer Joins BMEs (BioMedical Enterprises, Inc.) Board of Directors
3. BME (BioMedical Enterprises, Inc.) Announces U.S. Launch of the OSSArc(TM) Anatomic Residual Compression Implant
4. Coventina Healthcare Enterprises, Inc. is Now ReGear Life Sciences, Inc.
5. BME (BioMedical Enterprises, Inc.) Announces U.S. Launch of the OSSAnchor(TM) Grip Nitinol Soft Tissue Anchor
6. BME (BioMedical Enterprises, Inc.) Announces U.S. Launch of the Barbed OSStaple(TM) (BOSS) Nitinol Implant
7. BioMedical Enterprises, Inc. (BME) Announces the Appointment of Kenneth I. Moch as President and Chief Executive Officer
8. HEI, Inc. Closes on Sale of RFID Division Assets
9. Bally Total Fitness Emerges From Chapter 11 and Closes Transaction with Harbinger Capital Partners Funds
10. Actor Joe Pantoliano Discloses Depression; Talks About His Latest Movie and His Sensitive Side
11. Stryker Discloses Informal Inquiry Made by United States Securities and Exchange Commission
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... Coalition ... for Duchenne muscular dystrophy, and funding for Duchenne research, congratulates Capricor Therapeutics ... HOPE clinical trial in Duchenne announced today. , Coalition Duchenne funded studies ...
(Date:4/25/2017)... Boulder, CO (PRWEB) , ... April 25, 2017 ... ... Law and Liberty attempts to compare student test score performance for the 2015-16 ... one of the state’s voucher programs. Though it highlights important patterns in student ...
(Date:4/25/2017)... ... April 25, 2017 , ... Patients who ... achieves results in a fraction of the time as traditional braces – Wilckodontics®. ... Dental Specialists, now offers this revolutionary treatment with or without a referral. ...
(Date:4/25/2017)... ... April 25, 2017 , ... Back Pain Centers of America (BPC), ... reputable physician in their area, announces the launch of a new and proprietary customer ... are looking for reputable physicians to help them with back or neck pain and ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... of predictive analytics to its patient care management module. Using this new feature, ... a patient has been initiated on continuous positive airway pressure (CPAP), oral, or ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017  Sorrento Therapeutics, Inc. ... clinical-stage biopharmaceutical company developing new treatments for cancer ... closing of its previously announced underwritten public offering ... a public offering price of $2.00 per share, ... offering expenses payable by Sorrento.  The net proceeds ...
(Date:4/19/2017)... Calif. , April 19, 2017  SARES•REGIS ... buildings it is developing at Conejo Spectrum Business ... , to Atara Biotherapeutics, Inc. , a ... severe and life-threatening diseases that have been underserved ... allogeneic T-cell therapies for cancer, autoimmune and infectious ...
(Date:4/18/2017)... -- Research and Markets has announced the addition of ... offering. ... market to grow at a CAGR of 6.35% during the period ... has been prepared based on an in-depth market analysis with inputs ... growth prospects over the coming years. The report also includes a ...
Breaking Medicine Technology: